CN102631644B - External-use traditional Chinese medicine for treating myositis ossificans - Google Patents
External-use traditional Chinese medicine for treating myositis ossificans Download PDFInfo
- Publication number
- CN102631644B CN102631644B CN2012101412974A CN201210141297A CN102631644B CN 102631644 B CN102631644 B CN 102631644B CN 2012101412974 A CN2012101412974 A CN 2012101412974A CN 201210141297 A CN201210141297 A CN 201210141297A CN 102631644 B CN102631644 B CN 102631644B
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- chinese medicine
- external
- myositis ossificans
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
The invention relates to an external-use traditional Chinese medicine for treating myositis ossificans. The external-use traditional Chinese medicine comprises the following medicinal materials by weight part: 4-6 parts of flowers carthami, 20-30 parts of rhizoma sparganii, 20-30 parts of curcuma zedoary, 4-6 parts of frankincense, 4-6 parts of myrrh, 20-30 parts of Chinese elder, 20-30 parts of cape jasmine, 40-60 parts of coptis chinensis, 40-60 parts of golden cypress and 40-60 parts of radix sophorae flavescentis. According to the experiment, the external-use traditional Chinese medicine can treat myositis ossificans effectively and safely.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of external application Chinese medicine for the treatment of myositis ossificans.
Background technology
Myositis ossificans, refer to that calcification has occurred the normal tissue without calcification, also cries ectopic ossification.Myositis ossificans is due to after intraarticular or juxtra-articular fracture, dislocate, or after dislocation soon, before periosteum connects with bone photo again, carry out prematurely passive and powerful activity, make due to proliferation of fibrous tissue, osseous metaplasia.Be mainly in the muscle place at the positions such as joint, quadriceps femoris, adductor, upper arm flesh, little, buttocks, knee joint, shoulder, elbow.
Still lack at present medicine.Therefore the Chinese medicine of researching and developing a kind of safe and effective treatment and prevention myositis ossificans is very with practical value.
The present Research of the related medical material of Chinese medicine of the present invention is as follows:
The dried floral that Flos Carthami [source] this product is feverfew Flos Carthami Carthamus tinctorius L..[function cures mainly] promoting blood circulation to restore menstrual flow, eliminating stasis to stop pain.For amenorrhea, dysmenorrhea, lochia, the lump in the abdomen mass in the abdomen, injury from falling down, skin infection swells and ache.
The dry tuber that Rhizoma Sparganii [source] this product is Sparganiaceae plant rhizoma scirpi Sparganium stoloniferum Buch.-Ham..The circulation of qi promoting of [function cures mainly] removing blood stasis, the removing food stagnancy pain relieving.For the lump in the abdomen mass in the abdomen, blood stasis amenorrhea, food stagnation distending pain.
The dry rhizome that Rhizoma Curcumae [source] this product is zingiberaceous plant Rhizoma Curcumae Curcuma phaeocaulis Val., Guangxi zedoary Curcuma Kwangsiensis S. G.Lee et C. F. Liang or RADIX CURCUMAE Curcuma wenyujin Y.H. Chen et C. Ling.[function cures mainly] circulation of qi promoting removing blood stasis, the removing food stagnancy pain relieving.For Dan abdominal mass mass in the abdomen, blood stasis amenorrhea, food stagnation distending pain; Early cervical carcinoma.
Olibanum [source] Burseraceae Boswellia carterii platymiscium Boswellia carterii Boswellia carterii Birdw.[B. sacra Fluek.], medicine glue XIANGSHU B. bhawdajiana Birdw. and wild Boswellia carterii B. neglecta M. Moore etc., the oleo-gum-resin of oozing out with its trunk skin zone wound is used as medicine.[function cures mainly] promoting blood circulation and stopping pain.For all pains of trusted subordinate, the contracture of muscle arteries and veins, traumatic injury, sore, carbuncle and painful swelling; The externally used detumescence granulation promoting.
Myrrha [source] Burseraceae bdellium plant myrrh Commiphora myrrha Engl.[C. molmol Engl.] and belong to the oleo-gum-resin that the trunk skin zone of his kind of plant oozes out together.[function cures mainly] eliminating stasis to stop pain, the externally used detumescence granulation promoting.For traumatic injury congestion, swell and ache, ulcer sore pain, all pains of breast abdomen; External is controlled the open sore part and is not restrained for a long time.
The Pseudobulbus Bletillae (Rhizoma Bletillae) [source] this product is orchid Pseudobulbus Bletillae (Rhizoma Bletillae) Bletilla striata(Thunb.) dry tuber of Reichb. f..[function cures mainly] astringing to arrest bleeding, detumescence and promoting granulation.For hemoptysis, spit blood, traumatic hemorrhage, sore swollen toxin, chapped skin; The pulmonary tuberculosis hemoptysis, ulcer haemorrhage.
The dry mature fruit that Fructus Gardeniae [source] this product is Maguireothamnus speciosus Fructus Gardeniae Gardenia jasminoides Ellis.[function cures mainly] fruit: pathogenic fire purging relieving restlessness, clearing away heat and promoting diuresis, removing pathogenic heat from blood and toxic substance from the body.Vexed for calentura, the jaundice dark coloured urine, blood strangury and dry pain, heat in blood is told nosebleed, conjunctival congestion and swelling pain, pathogenic fire,toxin and furuncles; External treatment bruise pain.
The dry rhizome that Rhizoma Coptidis [source] this product is ranunculaceae plant Rhizoma Coptidis Coptis chinensis Franch., Coptis deltoidea C.Y.Cheng et Hsiao Coptis deltoidea C. Y. Cheng et Hsiao or Coptis Teeta Wall Coptis teeta Wall..[function cures mainly] heat clearing and damp drying, eliminating fire and detoxication.For damp and hot feeling of fullness, the vomiting acid regurgitation, dysentery, jaundice, unconsciousness due to high fever, hyperactivity of heart-fire, dysphoria and insomnia, heat in blood is told nosebleed, conjunctival congestion, toothache, quench one's thirst, the carbuncle furuncle; External treatment eczema, eczema, auditory meatus is suppurated.The kind clear part of the body cavity above the diaphragm housing the heart and lungs of Rhizoma Coptidis (processed with wine) is burning hot.For conjunctival congestion, aphtha.Prepared RHIZOMA COPTIDIS with rhizoma zingiberis recens juice clearing stomach stomach function regulating preventing or arresting vomiting.Tie mutually damp and hot middle resistance, feeling of fullness vomiting for cold and heat.Cornel Rhizoma Coptidis soothing liver-QI stomach function regulating preventing or arresting vomiting.For incoordination between the liver and stomach, the vomiting acid regurgitation.
The dry bark that Cortex Phellodendri [source] this product is rutaceae wampee Phellodendron chinense Schneid. or Cortex Phellodendri Phellodendron amurense Rupr..[function cures mainly] heat clearing and damp drying, pathogenic fire purging is except steaming, detoxification sore treatment.For damp-heat dysentery, jaundice, leukorrhagia, pyretic stranguria, beriberi, flaccidity { is warded off }, hectic fever due to YIN-deficiency consumptive fever, night sweat, seminal emission, sore swollen toxin, eczema pruritus.The stir-baked CORTEX PHELLODENDRI with salt solution nourishing YIN to lower pathogenic fire.For hyperactivity of fire caused by deficiency of YIN, the night sweat hectic fever due to YIN-deficiency.
The dry root that Radix Sophorae Flavescentis [source] this product is leguminous plant Radix Sophorae Flavescentis Sophora flavescens Ait..[function cures mainly] heat clearing and damp drying, parasite killing, diuresis.For hematodiarrhoea, have blood in stool, jaundice urine retention, leucorrhea with red and white discharge, swelling of the vulva pudendal pruritus, eczema, eczema, skin pruritus, scabies leprosy; External treatment trichomonal vaginitis.
Summary of the invention
The present invention aims to provide a kind of external application Chinese medicine for the treatment of myositis ossificans, by selecting suitable medical material and proportioning thereof, reaches the purpose of safe and effective healing laryngopharynx swelling and pain.
In order to achieve the above object, the present invention is by the following technical solutions:
A kind of external application Chinese medicine for the treatment of myositis ossificans, it is characterized in that, it is comprised of the medical material of following weight portion: Flos Carthami 4-6 part, Rhizoma Sparganii 20-30 part, Rhizoma Curcumae 20-30 part, Olibanum 4-6 part, Myrrha 4-6 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 20-30 part, Fructus Gardeniae 20-30 part, Rhizoma Coptidis 40-60 part, Cortex Phellodendri 40-60 part, Radix Sophorae Flavescentis 40-60 part.
Wherein preferred: 5 parts, Flos Carthami, 25 parts of Rhizoma Sparganii, 25 parts of Rhizoma Curcumae, 5 parts of Olibanums, 5 parts of Myrrhas, 25 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 25 parts of Fructus Gardeniaes, 50 parts of Rhizoma Coptidis, 50 parts of Cortex Phellodendris, 50 parts of Radix Sophorae Flavescentiss.
Below in conjunction with theory of Chinese medical science, the beneficial effect that we are bright is described:
The inventor finds in practice process, myositis ossificans be because of the wound stasis of blood stagnant, qi-blood disharmony due to, therefore treatment should be take blood circulation promoting and blood stasis dispelling, clearing away heat and alleviating pain as main.The present invention uses Flos Carthami, Rhizoma Sparganii, Rhizoma Curcumae, Olibanum, Myrrha promoting blood circulation, removing blood stasis and relieving pain; Fructus Gardeniae, Rhizoma Coptidis, Cortex Phellodendri, Radix Sophorae Flavescentis, heat-clearing and toxic substances removing; Pseudobulbus Bletillae (Rhizoma Bletillae) convergence granulation promoting; All medicines share, blood circulation promoting and blood stasis dispelling, clearing away heat and alleviating pain, thereby treatment and prevention myositis ossificans.
Below in conjunction with clinical experiment data declaration beneficial effect of the present invention:
1, physical data
The inventor in October, 2009-2010 collects the out-patient of 75 routine myositis ossificans altogether between year April, male 43 examples wherein, female's 32 examples, age 12-45 year, the course of disease 2 days-3 years.Be divided at random: treatment group 50 examples, matched group 25 examples.The data there was no significant differences such as two groups of sexes, age, have comparability.
2, test method
Matched group is coated with Moschus blood-circulation and removing blood stasis ointment, every day 2-4 time outside affected part.1 week course for the treatment of.
The sweet unguentum obliterating affected part that treatment group is used optimization formula of the present invention to make according to specific embodiment 1, every day 2-4 time.1 week course for the treatment of.
3, criterion of therapeutical effect and therapeutic outcome
3.1 criterion of therapeutical effect
Recovery from illness: clinical symptoms all disappears, and the test chamber inspection is normal.Take a turn for the better: clinical symptom relief, lab testing improves or is normal.Invalid: clinical symptoms is without being clearly better or increasing the weight of.
3.2 treatment statistical result is in Table 1.
Table 1 liang group curative effect relatively
| Group | n | Recovery from illness | Take a turn for the better | Invalid | The untoward reaction example | Total effective rate (%) |
| Treatment group | 50 | 6 | 42 | 2 | 0（0%） | 96% |
| Matched group | 25 | 2 | 10 | 13 | 0（0%） | 48% |
Visible, the medicine that the preferred embodiment for the present invention makes can safe and effective treatment myositis ossificans.
According to above-mentioned clinical experiment data, treat Chinese medicine Analysis on Mechanism and the general knowledge known in this field of myositis ossificans in conjunction with the present invention, those skilled in the art easily know by inference, use the medical material in the present invention, near value optimum weight part, at least, in the scope of " Flos Carthami 4-6 part, Rhizoma Sparganii 20-30 part, Rhizoma Curcumae 20-30 part, Olibanum 4-6 part, Myrrha 4-6 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 20-30 part, Fructus Gardeniae 20-30 part, Rhizoma Coptidis 40-60 part, Cortex Phellodendri 40-60 part, Radix Sophorae Flavescentis 40-60 part ", can obtain the similar technique effect of the medicine made with the preferred embodiment for the present invention.
The specific embodiment
In order to understand better and to implement the present invention, below in conjunction with specific embodiment, further illustrate the present invention.
Specific embodiment 1
Take 5 parts, Flos Carthami, 25 parts of Rhizoma Sparganii, 25 parts of Rhizoma Curcumae, 5 parts of Olibanums, 5 parts of Myrrhas, 25 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 25 parts of Fructus Gardeniaes, 50 parts of Rhizoma Coptidis, 50 parts of Cortex Phellodendris, 50 parts of Radix Sophorae Flavescentiss; Add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, drying, be ground into powdery, adds proper honey to be in harmonious proportion, and obtains sweet unguentum.
Be used for the treatment of myositis ossificans.Get appropriate obliterating affected part, every day 2-4 time.
Specific embodiment 2
Take 4 parts, Flos Carthami, 20 parts of Rhizoma Sparganii, 20 parts of Rhizoma Curcumae, 4 parts of Olibanums, 4 parts of Myrrhas, 20 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 20 parts of Fructus Gardeniaes, 40 parts of Rhizoma Coptidis, 40 parts of Cortex Phellodendris, 40 parts of Radix Sophorae Flavescentiss; Add 10 times of water gagings, decoct 2 hours, filter; Filtering residue adds 8 times of water gagings, decocts 1.5 hours, filters; Merging filtrate, concentrated, drying, be ground into powdery, adds proper honey to be in harmonious proportion, and obtains sweet unguentum.
Be used for the treatment of myositis ossificans.Get appropriate obliterating affected part, every day 2-4 time.
Specific embodiment 3
Take 6 parts, Flos Carthami, 30 parts of Rhizoma Sparganii, 30 parts of Rhizoma Curcumae, 6 parts of Olibanums, 6 parts of Myrrhas, 30 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 30 parts of Fructus Gardeniaes, 60 parts of Rhizoma Coptidis, 60 parts of Cortex Phellodendris, 60 parts of Radix Sophorae Flavescentiss; Add 6 times of water gagings, decoct 3 times, decoct 1 hour at every turn, merge decoction liquor, concentrated, drying, be ground into powdery, adds proper honey to be in harmonious proportion, and obtains sweet unguentum.
Be used for the treatment of myositis ossificans.Get appropriate obliterating affected part, every day 2-4 time.
Claims (1)
1. an external application Chinese medicine for the treatment of myositis ossificans, it is characterized in that, it is comprised of the medical material of following weight portion: 5 parts, Flos Carthami, 25 parts of Rhizoma Sparganii, 25 parts of Rhizoma Curcumae, 5 parts of Olibanums, 5 parts of Myrrhas, 25 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 25 parts of Fructus Gardeniaes, 50 parts of Rhizoma Coptidis, 50 parts of Cortex Phellodendris, 50 parts of Radix Sophorae Flavescentiss.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101412974A CN102631644B (en) | 2012-05-09 | 2012-05-09 | External-use traditional Chinese medicine for treating myositis ossificans |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101412974A CN102631644B (en) | 2012-05-09 | 2012-05-09 | External-use traditional Chinese medicine for treating myositis ossificans |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102631644A CN102631644A (en) | 2012-08-15 |
| CN102631644B true CN102631644B (en) | 2013-12-04 |
Family
ID=46616328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012101412974A Active CN102631644B (en) | 2012-05-09 | 2012-05-09 | External-use traditional Chinese medicine for treating myositis ossificans |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102631644B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104971244A (en) * | 2015-06-29 | 2015-10-14 | 程明国 | Externally-used medicine for treating myositis ossificans |
| CN104998102A (en) * | 2015-06-29 | 2015-10-28 | 苗光丽 | Externally applied drug for preventing myositis ossificans after elbow fracture |
| CN105031320A (en) * | 2015-06-29 | 2015-11-11 | 李克军 | Method for preparing externally applied medicament for myositis ossificans |
| CN112826906A (en) * | 2021-01-21 | 2021-05-25 | 陈小萍 | Antiviral transdermal drug and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101297946B (en) * | 2008-06-24 | 2011-05-25 | 孙兆印 | Plaster for activating blood and resolving stasis, dispelling wind and freeing collateral vessels and producing method thereof |
| CN102085283A (en) * | 2009-12-03 | 2011-06-08 | 吴延义 | Traditional Chinese medicament for treating myositis ossificans |
-
2012
- 2012-05-09 CN CN2012101412974A patent/CN102631644B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101297946B (en) * | 2008-06-24 | 2011-05-25 | 孙兆印 | Plaster for activating blood and resolving stasis, dispelling wind and freeing collateral vessels and producing method thereof |
| CN102085283A (en) * | 2009-12-03 | 2011-06-08 | 吴延义 | Traditional Chinese medicament for treating myositis ossificans |
Non-Patent Citations (2)
| Title |
|---|
| 中药内服外洗治疗肘关节骨化性肌炎21例;徐翔等;《安徽中医临床杂志》;20010628;第13卷(第03期);189 * |
| 徐翔等.中药内服外洗治疗肘关节骨化性肌炎21例.《安徽中医临床杂志》.2001,第13卷(第03期), |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102631644A (en) | 2012-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102008685B (en) | Chinese medicinal powder for treating liver cancer, lung cancer and pancreatic cancer | |
| CN102631644B (en) | External-use traditional Chinese medicine for treating myositis ossificans | |
| CN101085240B (en) | Oral decoction for treating aphtha | |
| CN102631454B (en) | Externally used traditional Chinese medicine for curing fracture postoperation synarthrophysis | |
| CN103800759B (en) | One treats person in middle and old age's rheumatism, rheumatoid Chinese medicine | |
| CN103611097B (en) | One treats innominate toxic swelling Chinese medicine | |
| CN104491456A (en) | Impediment eliminating and collateral dredging paste for knee joint rheumatic arthritis and preparation | |
| CN103656323A (en) | Traditional Chinese medicine for treating erythroderma-type psoriasis | |
| CN103705614B (en) | Traditional Chinese medicine for treating herpes zoster | |
| CN103520594B (en) | Traditional Chinese medicine for treating interior dampness-heat syndrome type acne disease | |
| CN103989790A (en) | Traditional Chinese medicinal lotion for treating colpitis mycotica and preparation method thereof | |
| CN103610784B (en) | Traditional Chinese medicine for treating periodontal abscess | |
| CN103610995B (en) | A kind of Chinese medicine for the treatment of gingivitis | |
| CN104666541A (en) | Traditional Chinese medicine for treating acute typical intestinal amebiasis | |
| CN103638506B (en) | A kind of Chinese medicine for the treatment of arthromyodynia | |
| CN103566226B (en) | Traditional Chinese medicament for treating suppurative pneumonia | |
| CN103536741B (en) | External-use Chinese medicine for prompting anal fistula postoperative recovery | |
| CN103610815B (en) | A kind of Chinese medicine for the treatment of cellulitis | |
| CN105233193A (en) | Traditional Chinese medicine treating coronary heart disease | |
| CN103705819B (en) | A kind of Chinese medicine treating intestinal Behcet disease | |
| CN102908450B (en) | Traditional Chinese medicine for treating nutritional edema | |
| CN103735699A (en) | Traditional Chinese medicinal composition for treating scald and preparation method thereof | |
| CN103520568B (en) | A kind of Chinese medicine for the treatment of the qi depression to blood stasis pattern of syndrome thoracic obstruction | |
| CN103610993B (en) | A kind of Chinese medicine for the treatment of kindred internal injury | |
| CN103611098B (en) | Traditional Chinese medicine for treating pruritus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20220119 Address after: 712000 Jianchi plant of American science and Technology Industrial Park, Yongle Town, Jinghe new town, Xixian new area, Xi'an, Shaanxi Patentee after: Shaanxi guyuantang Health Industry Co.,Ltd. Address before: 264000 Yantai Hospital of traditional Chinese medicine, 39 happiness Road, Zhifu District, Shandong, Yantai Patentee before: Yan Wanli |